AVTX
Price
$6.59
Change
-$0.49 (-6.92%)
Updated
Apr 3 closing price
Capitalization
71.4M
MEOBF
Price
$1.37
Change
-$0.25 (-15.43%)
Updated
Mar 12 closing price
Capitalization
1.5B
54 days until earnings call
Ad is loading...

AVTX vs MEOBF

Header iconAVTX vs MEOBF Comparison
Open Charts AVTX vs MEOBFBanner chart's image
Avalo Therapeutics
Price$6.59
Change-$0.49 (-6.92%)
Volume$41.24K
Capitalization71.4M
Mesoblast
Price$1.37
Change-$0.25 (-15.43%)
Volume$135
Capitalization1.5B
AVTX vs MEOBF Comparison Chart
Loading...
AVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVTX vs. MEOBF commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVTX is a Buy and MEOBF is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (AVTX: $6.69 vs. MEOBF: $1.37)
Brand notoriety: AVTX and MEOBF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVTX: 59% vs. MEOBF: 14%
Market capitalization -- AVTX: $71.4M vs. MEOBF: $1.5B
AVTX [@Biotechnology] is valued at $71.4M. MEOBF’s [@Biotechnology] market capitalization is $1.5B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVTX’s FA Score shows that 0 FA rating(s) are green whileMEOBF’s FA Score has 0 green FA rating(s).

  • AVTX’s FA Score: 0 green, 5 red.
  • MEOBF’s FA Score: 0 green, 5 red.
According to our system of comparison, MEOBF is a better buy in the long-term than AVTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVTX’s TA Score shows that 5 TA indicator(s) are bullish.

  • AVTX’s TA Score: 5 bullish, 4 bearish.

Price Growth

AVTX (@Biotechnology) experienced а -23.37% price change this week, while MEOBF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.91%. For the same industry, the average monthly price growth was -11.19%, and the average quarterly price growth was -14.86%.

Reported Earning Dates

AVTX is expected to report earnings on Apr 01, 2024.

MEOBF is expected to report earnings on May 28, 2025.

Industries' Descriptions

@Biotechnology (-8.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MEOBF($1.5B) has a higher market cap than AVTX($71.4M). AVTX YTD gains are higher at: -11.306 vs. MEOBF (-37.727). AVTX has higher annual earnings (EBITDA): -35.84M vs. MEOBF (-77.78M). AVTX has more cash in the bank: 81.9M vs. MEOBF (37.7M). AVTX has less debt than MEOBF: AVTX (550K) vs MEOBF (126M). MEOBF has higher revenues than AVTX: MEOBF (5.67M) vs AVTX (820K).
AVTXMEOBFAVTX / MEOBF
Capitalization71.4M1.5B5%
EBITDA-35.84M-77.78M46%
Gain YTD-11.306-37.72730%
P/E Ratio0.09N/A-
Revenue820K5.67M14%
Total Cash81.9M37.7M217%
Total Debt550K126M0%
FUNDAMENTALS RATINGS
AVTX vs MEOBF: Fundamental Ratings
AVTX
MEOBF
OUTLOOK RATING
1..100
9038
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
89
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9795
PRICE GROWTH RATING
1..100
6339
P/E GROWTH RATING
1..100
8750
SEASONALITY SCORE
1..100
n/a46

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AVTX's Valuation (85) in the Pharmaceuticals Other industry is in the same range as MEOBF (89) in the null industry. This means that AVTX’s stock grew similarly to MEOBF’s over the last 12 months.

AVTX's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as MEOBF (100) in the null industry. This means that AVTX’s stock grew similarly to MEOBF’s over the last 12 months.

MEOBF's SMR Rating (95) in the null industry is in the same range as AVTX (97) in the Pharmaceuticals Other industry. This means that MEOBF’s stock grew similarly to AVTX’s over the last 12 months.

MEOBF's Price Growth Rating (39) in the null industry is in the same range as AVTX (63) in the Pharmaceuticals Other industry. This means that MEOBF’s stock grew similarly to AVTX’s over the last 12 months.

MEOBF's P/E Growth Rating (50) in the null industry is somewhat better than the same rating for AVTX (87) in the Pharmaceuticals Other industry. This means that MEOBF’s stock grew somewhat faster than AVTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVTX
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
89%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 8 days ago
85%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
83%
Aroon
ODDS (%)
Bullish Trend 1 day ago
76%
View a ticker or compare two or three
Ad is loading...
AVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GOTU2.99-0.06
-1.97%
Gaotu Techedu
CIX20.32-0.91
-4.29%
Comp X International
TM168.07-9.24
-5.21%
Toyota Motor Corp
FUTU97.49-5.98
-5.78%
Futu Holdings Limited
IOBT1.00-0.06
-6.07%
IO Biotech

AVTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVTX has been loosely correlated with FGEN. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if AVTX jumps, then FGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVTX
1D Price
Change %
AVTX100%
-6.92%
FGEN - AVTX
57%
Loosely correlated
-3.89%
MEOBF - AVTX
46%
Loosely correlated
N/A
MRSN - AVTX
37%
Loosely correlated
-9.94%
CELC - AVTX
37%
Loosely correlated
-5.45%
PGEN - AVTX
34%
Loosely correlated
-9.46%
More

MEOBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, MEOBF has been loosely correlated with SPHDF. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if MEOBF jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MEOBF
1D Price
Change %
MEOBF100%
N/A
SPHDF - MEOBF
50%
Loosely correlated
N/A
AVTX - MEOBF
46%
Loosely correlated
-5.51%
COGT - MEOBF
39%
Loosely correlated
-6.73%
MESO - MEOBF
26%
Poorly correlated
-1.78%
KROS - MEOBF
26%
Poorly correlated
+2.39%
More